Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells | Science
Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells
How farming protects against allergies
People who grow up on dairy farms only rarely develop asthma or allergies. This is probably because as children, they breathe air containing bacterial components, which reduce the overall reactivity of the immune system. Schuijs et al. chronically exposed mice to bacterial endotoxin before they received an allergic stimulus. The protocol indeed protected them from developing an allergic response. Protection relied on a particular enzyme: A20. In humans, a variant of A20 correlates with increased susceptibility to asthma and allergy in children growing up on farms.
Science, this issue p. 1106
Abstract
Growing up on a dairy farm protects children from allergy, hay fever, and asthma. A mechanism linking exposure to this endotoxin (bacterial lipopolysaccharide)–rich environment with protection has remained elusive. Here we show that chronic exposure to low-dose endotoxin or farm dust protects mice from developing house dust mite (HDM)–induced asthma. Endotoxin reduced epithelial cell cytokines that activate dendritic cells (DCs), thus suppressing type 2 immunity to HDMs. Loss of the ubiquitin-modifying enzyme A20 in lung epithelium abolished the protective effect. A single-nucleotide polymorphism in the gene encoding A20 was associated with allergy and asthma risk in children growing up on farms. Thus, the farming environment protects from allergy by modifying the communication between barrier epithelial cells and DCs through A20 induction.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
Summary
Materials and Methods
Figs. S1 to S5
Tables S1 and S2
Resources
File (schuijs.sm.pdf)
- Download
- 961.86 KB
References and Notes
(0)eLetters
eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.
Log In to Submit a ResponseNo eLetters have been published for this article yet.
Recommended articles from TrendMD
-
How farming protects against allergies
Kristen L. Mueller, Sci Signal, 2015
-
Universal flu vaccine is ‘an alchemist's dream’
Jon Cohen, Science, 2018
-
Broadly Protective Vaccine for Staphylococcus aureus Based on an in Vivo-Expressed Antigen
David McKenney et al., Science, 1999
-
Dysregulated invertebrate tropomyosin–dectin-1 interaction confers susceptibility to allergic diseases
Naina Gour et al., Sci Immunol, 2018
-
Controversy over dengue vaccine risk
Jon Cohen, Science, 2019
-
Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cells
Sisi Chen et al., Cell Discovery, 2022
-
Muscularis macrophages: trained guardians of enteric neurons
Maria Francesca Viola et al., Cell Research, 2021
-
Etiology of lung cancer: Evidence from epidemiologic studies
Kaiyong Zou et al., Journal of the National Cancer Center, 2022
-
How to dodge pyroptosis: lessons from Shigella flexneri
Van Hauwermeiren et al., Cell Research, 2021
-
An LC-MS/MS method for simultaneous analysis of the cystic fibrosis therapeutic drugs colistin, ivacaftor and ciprofloxacin
Huiya Yuan et al., Journal of Pharmaceutical Analysis, 2021
Current Issue
Advertisement
Sign up for ScienceAdviser
Subscribe to ScienceAdviser to get the latest news, commentary, and research, free to your inbox daily.
Subscribe